Health and Nutrition >
Diseases >
A
Health Centres - Aplastic anaemia
Written by Professor TJ Hamblin, consultant haematologist
What is it?'Aplasia' means the lack of development of a tissue, cell or other body part. Aplastic anaemia is the condition in which the bone marrow fails to produce blood cells. Normally, the bone marrow produces:
- red blood cells (which carry oxygen in the blood)
- various types of white blood cell (which are part of the immune system)
- platelets (which are involved in blood clotting).
Each of these different types of blood cell originates from simpler cells, known as precursors or stem cells, which develop into the more specialised forms.
There are numerous reasons for the bone marrow to fail to produce blood cells in adequate numbers, but in aplastic anaemia there is a marked deficiency of all the precursor cells that should mature into adult blood cells.
Is it common?
No, aplastic anaemia is a rare disease with an incidence in industrialised countries of between 5 and 10 cases per million per year.
How do I get aplastic anaemia?
In 65 per cent of people the cause of aplastic anaemia is unknown (the technical term is 'idiopathic').
Rarely, the disease is present at birth (congenital). The commonest congenital form is Fanconi's syndrome, but fewer than 1000 cases have ever been described.
As well as aplastic anaemia, patients with Fanconi's syndrome have short stature, abnormal skin pigmentation, abnormalities of the bones of their arms and thumbs, kidney problems and an elfin-like appearance. A characteristic abnormality of the chromosomes (random breaks) is seen.
Drugs and environmental toxins
The commonest known cause of aplastic anaemia is exposure to drugs or environmental toxins.
Benzene was the first known toxin to cause bone marrow failure. Despite this it is still widely used in industry in the manufacture of drugs, dyes, explosives and other chemicals. Exposure should be limited to 1 part per million, but this is often exceeded, especially in developing countries. Other related organic chemicals also cause aplastic anaemia, including:
- toluene (in glues)
- the insecticides DDT and lindane
- the explosive TNT
- the wood preservative PCP
- petroleum distillates.
Drugs that cause aplastic anaemia may also be related to benzene. The antibiotic, chloramphenicol and the anti-inflammatory, phenylbutazone are two examples. Neither is commonly used in Western countries, but because they are cheap to produce, they are in widespread use in the developing world. Other medicines with a moderate risk of aplastic anaemia include gold salts and penicillamine, used to treat arthritis, carbamazepine
and phenytoin, used to treat epilepsy, and the diuretic acetazolamide.
A large number of drugs have been associated with occasional cases of aplastic anaemia. Most of these are useful drugs and cannot easily be replaced.
In Britain, doctors use a system called the 'yellow-card' scheme to report suspected side effects of drugs, such as aplastic anaemia.
Cytotoxic drugs are those that are designed to be directly toxic to cells in the treatment of cancer. Some destroy bone marrow cells (for example, in the treatment of leukaemia). Normally the marrow recovers after a short period. An overdose of these drugs causes severe, prolonged aplasia.
Radiotherapy (treatment with X-rays) suppresses the bone marrow, and may be intentionally used to do so in preparation for bone marrow transplantation. The use of these treatments should be confined to specialised centres where careful monitoring of the blood count takes place.
Some cases of aplastic anaemia have occurred after viral infections. In particular, hepatitis A, hepatitis B and 'non-A, non-B, non-C' hepatitis have been implicated, and more rarely the Epstein-Barr virus.
Very rarely aplastic anaemia occurs during pregnancy. It is not clear whether this is just a coincidence. Sometimes the disease recovers spontaneously at the end of pregnancy.
What is the disease process?
. Nowadays, treatment of aplastic anaemia is directed on the assumption that the disease is related to the immune system.
The first evidence for this came from the early days of bone marrow transplantation. Sometimes the marrow that regrew after the conditioning treatment was of the person's own type rather than that of the donor. This implied that there had been an immune attack going on in the person's bone marrow, which was relieved by the intense dampening down of his or her immune system by the treatment.
Other evidence comes from immunodeficient individuals (ie those with impaired immunity either through disease or caused by their treatment) who receive a blood transfusion. They sometimes develop transfusion-related graft-versus-host disease (GvHD) â in other words a rejection response. One of the forms that it can take is aplastic anaemia, demonstrating that an immunological attack can cause aplastic anaemia.
What are the symptoms?
The person complains of increasing tiredness, weakness and shortness of breath. Bleeding, bruising and blood spots may be noticed.
Sore throats and other infections are noticeable. A high temperature with shivering attacks is an important symptom that demands immediate medical attention.
How is aplastic anaemia diagnosed?
The following combination of three symptoms should raise suspicion of bone marrow failure:
- anaemia - tiredness, weakness and breathlessness
- low white cell count in the blood (neutropenia) - fever, sore throat, shivering attacks
- low platelet count (thrombocytopenia) - bruising and bleeding.
On examination the doctor may find pale skin, possibly the signs of heart failure, bruises and petechiae (small blood spots in the skin and mouth), mouth ulcers and fever.